Salvage Radical Prostatectomy Offers Good Long-Term Outcomes

Share this content:
Salvage radical prostatectomy offers good long-term oncologic outcomes among patients who experience recurrence.
Salvage radical prostatectomy offers good long-term oncologic outcomes among patients who experience recurrence.

SAN DIEGO—Salvage radical prostatectomy (SRP) offers good long-term oncologic outcomes among patients who experience recurrence of prostate cancer (PCa) after radiotherapy, data presented at the American Urological Association's 2016 annual meeting.

Antoni Vilaseca, MD, and colleagues at Memorial Sloan-Kettering Cancer Center in New York, studied 251 men with a median age of 65 years who underwent SRP for biopsy-proven radiorecurrent PCa after external beam radiation therapy, brachytherapy, or both. Of these, 221 underwent open SRP and 30 had minimally invasive surgery (MIS). In addition to long-term oncologic outcomes of SRP, the investigators looked at whether MIS can reduce the incidence of bladder neck contracture (BNC).

The 5- and 10-year cancer-specific survival rates were 92% and 78%, respectively, and the 5- and 10-year overall survival rates were 87% and 64%, respectively, the investigators reported. The 1- and 3-year BNC-free survival rates were 81% and 73%, respectively. Patients who underwent MIS had significantly better BNC-free survival compared with those who had open surgery.

Extraprostatic extension, lymph node invasion, seminal vesicle invasion, and positive surgical margins were present in 69%, 22%, 32%, and 17% of patients, respectively. Fifty patients died, 27 from PCa.

RELATED: Baseline PSA at Age 55-60 Predicts Risk for Prostate Cancer

“Although functional outcomes and complications are worse in the salvage treatment setting,” the authors concluded in a poster presentation, “among patients undergoing SRP, minimally invasive compared to open techniques is associated with better BNC-free survival.”

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs